Tissue transparentizing and three-dimensional dyeing method and application

Through the method of formaldehyde and polyacrylamide hydrogel fixation and gradual dehydration and rehydration, combined with specific chemical treatment, the contraction and fluorescence signal problems in human skin tissue transparency and dyeing are solved, and efficient tissue transparency and dyeing are achieved. Ensure the integrity of the microstructure and the stability of the fluorescence signal.

CN118980558APending Publication Date: 2024-11-19GUANGZHOU YINUO BIOTECHNOLOGY CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410747378.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-11
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The prior art is difficult to effectively transparent and three-dimensionally dye human skin tissue, resulting in problems such as tissue shrinkage, antibodies difficult to enter the deep layer, fluorescence signals are easily quenched, microstructure cannot be completely retained, and secondary utilization cannot be used.

Method used

The tissue is fixed by formaldehyde and polyacrylamide hydrogels, combined with dichloromethane/methanol pretreatment and hydrogen peroxide bleaching, and hydration is performed using Triton X-100, DMSO and glycine to ensure the antibody Permeability and fluorescence signal stability.

Benefits of technology

The stability and transparency of the tissue structure are achieved, ensuring the uniform distribution of the antibody and the specificity of the fluorescent signal, avoiding tissue contraction and quenching of the fluorescent signal, and the microstructure is clearly visible, which significantly improves the transparency speed and effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004886822240000011
    Figure HDA0004886822240000011
  • Figure HDA0004886822240000012
    Figure HDA0004886822240000012
  • Figure HDA0004886822240000021
    Figure HDA0004886822240000021
Patent Text Reader

Abstract

The invention relates to the field of tissue repair and regeneration, and discloses a tissue transparentizing and three-dimensional dyeing method and application. The method comprises the following steps: S1, fixing a tissue sample; s2, gradually dehydrating the tissue sample and then cleaning; s3, pretreating the tissue sample; s4, decolorizing the tissue sample; s5, gradually rehydrating the tissue sample; s6, hydrating the tissue sample; s7, performing tissue dyeing on the tissue sample; and S8, incubating the tissue sample until the tissue sample is transparent, and imaging. The method is suitable for human skin tissues, does not cause obvious tissue shrinkage in the use process, can completely retain a microstructure, is high in transparency speed and excellent in effect, and does not cause quenching of a fluorescence signal.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of tissue repair and regeneration, and more specifically, to a tissue transparency and three-dimensional staining method and application. Background Art

[0002] In clinical practice, full-thickness skin defects are common in trauma, burns, and refractory ulcers. As a template for inducing dermal regeneration, dermal scaffolds provide an ideal way to treat deep skin defects. In the process of developing dermal scaffolds, accurate analysis of the microscopic three-dimensional distribution and mutual spatial relationship of skin tissue and its appendages is necessary to achieve the development of highly bionic dermal scaffolds.

[0003] However, traditional methods, such as frozen sections, have obvious disadvantages. They cannot observe the structural network on a continuous 3D level, are labor-intensive and damage nerve tissue, and are slow to take images, generally requiring at least several weeks. Therefore, it is essential to establish a complete tissue transparency and staining technology, which can provide data support for the spatial structural analysis of important components of human skin and the preparation of customized highly bionic dermal scaffolds.

[0004] According to the solvents used in each clearing method and their working principles, the existing tissue clearing methods are mainly divided into three categories: organic solvent type, water solvent type, and hydrogel type.

[0005] Organic solvent-based clearing methods use high-refractive-index organic solvents to homogenize the refractive index of different components to achieve excellent tissue transparency. For example, the BABB clearing method uses ethanol dehydration and a mixed solvent of tetrahydrofuran (THF) and dibenzyl ether (DBE), but there is a problem that ethanol dehydration will quench the endogenous fluorescence signal; 3DISCO and uDISCO clearing methods use THF and DBE solvents to achieve good transparency, but DBE degradation products may interfere with fluorescent proteins.

[0006] Water-based clearing methods use aqueous reagents, which are highly hydrophilic and conducive to the preservation of fluorescent signals. For example, the ClearT and ClearT2 clearing methods use aqueous reagents such as formamide and polyethylene glycol, but may cause tissue swelling and fluorescent signal quenching; the SeeDB and FRUIT clearing methods use reagents such as fructose and thioglycerol to achieve tissue clearing within a few days, but the high viscosity of fructose leads to low permeability in the tissue.

[0007] The hydrogel-based clearing method uses hydrogels to form covalent bonds with proteins and nucleic acids in tissues to fix and protect cell structures. The CLARITY and SHIELD clearing methods are typical hydrogel-based clearing methods, which use gels to embed samples and use electric field forces or epoxy P3PE to fix tissues, and then use SDS for passive or active degreasing to achieve tissue clearing, but the operation process is complicated and requires specific equipment support.

[0008] In addition, the collagen density of human skin is usually higher, and the collagen fibers are more complex and densely arranged, forming a more solid support structure. It is therefore more difficult for immunofluorescent antibodies to penetrate deep into the tissue, which results in uneven staining and weak or invisible signals in deep structures. The high fat content of human skin can also interfere with the binding of antibodies. Due to the presence of more autofluorescent substances (such as lipofuscin) in human skin, high background signals are easily generated during immunofluorescence staining, affecting the identification of specific fluorescent signals. Therefore, the above difficulties pose a huge challenge to the three-dimensional staining of human skin tissue.

[0009] Prior art CN202211369454.7 uses mannose, a mixture of mannose and 1,3-dimethyl-2-imidazolidinone dissolved in a solvent to treat mouse skin tissue in vivo; CN201710193040.6 uses urea, formamide, Triton and N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine to treat mouse skin tissue samples. However, the above prior art is not suitable for treating human skin tissue, and the treated skin tissue samples cannot retain the microstructure completely, and the skin tissue samples cannot be reused later. Summary of the invention

[0010] The present invention provides a method for tissue transparency and three-dimensional staining to overcome the defects of the above-mentioned prior art, such as easy tissue shrinkage, unsuitability for human skin tissue, difficulty for antibodies to enter deep tissue layers, easy quenching of fluorescent signals, inability to completely preserve microstructures, and inability to recycle skin tissue samples.

[0011] Another object of the present invention is to provide an application of a tissue clearing and three-dimensional staining method.

[0012] In order to solve the above technical problems, the technical solution of the present invention is as follows:

[0013] A method for tissue clearing and three-dimensional staining comprises the following steps:

[0014] S1: Fix the tissue sample;

[0015] S2: gradually dehydrate the tissue samples and then wash them;

[0016] S3: pre-treating the tissue sample;

[0017] S4: decolorizing the tissue sample;

[0018] S5: gradually rehydrating the tissue sample;

[0019] S6: hydrating the tissue sample;

[0020] S7: After the tissue samples are washed, they are stained;

[0021] S8: Incubate tissue samples until transparent and ready for imaging.

[0022] Furthermore, in S1, the tissue sample is immersed in formaldehyde and polyacrylamide hydrogel for fixation; the volume concentration of formaldehyde is 3-5%, and the volume concentration of polyacrylamide hydrogel is 1-6%.

[0023] Furthermore, in S8, the tissue sample is immersed in formaldehyde and polyacrylamide hydrogel for incubation; the volume concentration of formaldehyde is 3-5%, and the volume concentration of polyacrylamide hydrogel is 2-8%.

[0024] In S1, the skin tissue is fixed in situ with a mixture of formaldehyde and polyacrylamide hydrogel. The formaldehyde cross-links with the biomolecules in the tissue and connects the hydrogel monomers to these biomolecules to form a hydrogel-tissue cross-linked body. Subsequently, the temperature is increased to promote the polymerization and cross-linking of the hydrogel monomers to form a dense three-dimensional network structure hydrogel, thereby supporting and fixing the overall structure of the tissue. In S8, the tissue sample is immersed in a mixture of formaldehyde and polyacrylamide hydrogel to match the refractive index and prevent fluorescence quenching.

[0025] Preferably, after completing S2, washing is performed with 100% methanol.

[0026] Furthermore, in S3, the tissue sample is immersed in methanol and dichloromethane for pretreatment; the volume ratio of methanol to dichloromethane is 1:2-4.

[0027] Preferably, after completing S3, washing is performed with 100% methanol.

[0028] Furthermore, in S4, the tissue sample is decolorized in hydrogen peroxide and methanol; the volume concentration of hydrogen peroxide is 4-6%.

[0029] Furthermore, the volume ratio of methanol to dichloromethane in S3 is 1:2-4, and the volume concentration of hydrogen peroxide in S4 is 4-6%.

[0030] Furthermore, in S6, the tissue sample is incubated and hydrated in Triton X-100, DMSO and glycine; the volume concentration of Triton X-100 is 0.2-5%, the volume concentration of DMSO is 10-20%, and the volume concentration of glycine is 0.2-0.4 mol / L.

[0031] Dichloromethane (DCM) / methanol (MeOH) pretreatment: Aims to reduce background interference and improve antibody diffusion, while alleviating tissue shrinkage caused by methanol dehydration. Use 5% hydrogen peroxide (H2O2) solution to bleach the sample to remove autofluorescence and ensure the clarity and accuracy of fluorescence imaging. Incubation in Triton X-100, DMSO, and glycine increases the permeability of the cell membrane, reduces nonspecific binding of antibodies, and ensures that the antibody is evenly distributed throughout the tissue sample.

[0032] Furthermore, the dehydration of S2 is carried out in methanol or ethanol with an increasing concentration gradient, and the rehydration of S5 is carried out in methanol or ethanol with a decreasing concentration gradient.

[0033] Preferably, the volume concentration gradient of methanol in S2 increases between 20% and 100%, and the volume concentration gradient of methanol in S5 decreases between 80% and 20%.

[0034] Dehydrate the tissue using different concentrations of methanol to prevent shrinkage and damage. Rehydrate the sample using gradually decreasing methanol concentrations to restore the tissue to its natural state.

[0035] Furthermore, the S7 tissue sample is washed and incubated with PBST before being stained; the volume concentration of the PBST is 0.2-5%.

[0036] Preferably, washing is performed with PBS.

[0037] Furthermore, the tissues include skin, blood vessels, nerves, muscles, bones, brain, heart, liver, kidneys and lungs of humans and other animals.

[0038] Preferably, the sample thickness for skin tissue is 0.3-2 mm.

[0039] An application of the tissue transparency and three-dimensional staining method is applied to the field of human skin tissue repair and regeneration.

[0040] Compared with the prior art, the technical solution of the present invention has the following beneficial effects:

[0041] (1) In order to solve the problem of dense collagen fibers in human skin, a specific concentration of polyacrylamide hydrogel and formaldehyde fixation were used to keep the tissue structure stable during the transparent process, while improving the permeability of antibodies, achieving uniform staining, and ensuring that the nerve fibers and vascular networks were clearly visible under the microscope. The pretreatment step of dichloromethane / methanol effectively removed the fat components in the skin tissue, reduced the interference with antibody binding, improved the binding efficiency of antibodies and target antigens, made the staining results more accurate, and enhanced the specificity of the fluorescent signal.

[0042] (2) No obvious tissue shrinkage: Polyacrylamide hydrogel and formaldehyde are used to fix tissues, so that the tissues maintain their original structure and morphology during the transparent process, avoiding the shrinkage and deformation phenomena commonly seen in traditional methods.

[0043] (3) Ability to completely preserve microstructure: With the support and fixation of polyacrylamide hydrogel and formaldehyde treatment, the microstructure within the tissue is effectively protected by precisely controlling the methanol concentration gradient during the dehydration and rehydration process, combined with the pretreatment steps of dichloromethane and methanol. After transparency and staining, fine structures such as nerve fibers and vascular networks are still clearly visible, ensuring the accuracy of observation under the microscope.

[0044] (4) Effectively avoid the quenching of fluorescence signals: hydrogen peroxide is used for bleaching to remove autofluorescence, ensure the stability and intensity of the fluorescent labeling, and make the signal after fluorescent staining clearly discernible. The addition of glycine significantly reduces background interference and improves the contrast and accuracy of fluorescence imaging.

[0045] (5) Significantly improved transparency speed and effect: With the transparent reagent and treatment steps of the present invention, the tissue can be transparentized efficiently in a short time, reducing the experimental cycle. The transparent tissue sample shows excellent transparency under the microscope, making the observation of the internal structure more intuitive and detailed. BRIEF DESCRIPTION OF THE DRAWINGS

[0046] Figure 1 Imaging the three-dimensional nerve and blood vessel network in human skin tissue in Example 1;

[0047] Figure 2 Imaging the three-dimensional neural and vascular network in human skin tissue in Example 2;

[0048] Figure 3 Imaging the three-dimensional neural and vascular network in human skin tissue in Example 3;

[0049] Figure 4 The transparent effect of human skin tissue, A is comparative example 1, B is comparative example 3;

[0050] Figure 5 The transparent effect and imaging of human skin tissue in Comparative Example 2;

[0051] Figure 6 This is the three-dimensional neural imaging of human skin tissue in Comparative Example 4. DETAILED DESCRIPTION

[0052] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0053] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.

[0054] The human skin samples used in the experiment of the present invention are human abdominal skin, provided by Shenzhen Second People's Hospital. The material acquisition process strictly abides by ethical norms and laws and regulations to ensure that the source of the samples is legal and compliant.

[0055] Example 1

[0056] 1. Human skin samples were immersed in a mixture of 4% formaldehyde and 3% polyacrylamide hydrogel and fixed at room temperature for 3 days.

[0057] 2. The fixed samples were dehydrated stepwise in 20, 40, 60, 80, and 100% methanol / water solutions for 1 h.

[0058] 3. Wash twice with 100% methanol for 1 hour each time and cool the sample to 4°C;

[0059] 4. Immerse the sample in a methanol / dichloromethane solution with a volume ratio of 1:3 and place it on a decolorizing shaker at room temperature overnight.

[0060] 5. After washing with 100% methanol for 2 × 1 h, the sample was bleached with 5% H2O2 methanol (the volume ratio of 30% H2O2 to methanol was 1:5) at 4°C overnight.

[0061] 6. Rehydrate the sample in 80, 60, 40, and 20% methanol / water solutions for 1 h.

[0062] 7. Wash the samples quickly with PBS and then incubate them in 3% PBST for 2 × 1 h. After this step, the samples were processed for immunostaining.

[0063] 8. The samples were incubated in PBS, 0.2% Triton X-100, 20% DMSO, and 0.3 mol / L glycine at 37°C for 24 h.

[0064] 9. Then block in PBS, 0.2% Triton X-100, 10% DMSO, 15% goat serum, and 6% BSA at 37°C for 24 h.

[0065] 10. The samples were incubated in PBS, 0.2% Triton X-100, 10% DMSO, 15% goat serum, 6% BSA, and primary antibody solution at 37°C for 6 days.

[0066] 11. Wash the samples 5 times in PBS, 0.2% Triton X-100 until the next day.

[0067] 12. Then incubate at 37°C for 4 days in PBS, 0.2% Triton X-100, 10% DMSO, 15% goat serum, 6% BSA, and fluorescent secondary antibody solution.

[0068] 13. Finally, wash five times in PBS, 0.2% Triton X-100 until the next day.

[0069] 14. Finally, the samples were incubated in a mixture of 4% formaldehyde and 4% polyacrylamide hydrogel at 37°C for 4 h until transparent and ready for imaging.

[0070] Example 2

[0071] 1. Human skin samples were immersed in a mixture of 3% formaldehyde and 1% polyacrylamide hydrogel and fixed at room temperature for 3 days.

[0072] 2. The fixed samples were dehydrated stepwise in 20, 40, 60, 80, and 100% methanol / water solutions for 1 h.

[0073] 3. Wash twice with 100% methanol for 1 hour each time and cool the sample to 4°C;

[0074] 4. Immerse the sample in a methanol / dichloromethane solution with a volume ratio of 1:2 and place it on a decolorizing shaker at room temperature overnight.

[0075] 5. After washing with 100% methanol for 2 × 1 h, the samples were bleached with 6% H2O2 methanol at 4°C overnight.

[0076] 6. Rehydrate the sample in 80, 60, 40, and 20% methanol / water solutions for 1 h.

[0077] 7. Wash the samples quickly with PBS and then incubate them in 0.2% PBST for 2 × 1 h. After this step, the samples were processed for immunostaining.

[0078] 8. The samples were incubated in PBS, 1% Triton X-100, 20% DMSO, and 0.4 mol / L glycine at 37°C for 24 h.

[0079] 9. Then block in PBS, 0.2% Triton X-100, 10% DMSO, 10% goat serum, and 10% BSA at 37°C for 24 h.

[0080] 10. The samples were incubated in PBS, 0.2% Triton X-100, 10% DMSO, 10% goat serum, 10% BSA, and primary antibody solution at 37°C for 6 days.

[0081] 11. Wash the samples 5 times in PBS, 0.2% Triton X-100 until the next day.

[0082] 12. Then incubate at 37°C for 4 days in PBS, 0.2% Triton X-100, 10% DMSO, 10% goat serum, 10% BSA, and fluorescent secondary antibody solution.

[0083] 13. Finally, wash five times in PBS, 0.2% Triton X-100 until the next day.

[0084] 14. Finally, the samples were incubated in a mixture of 3% formaldehyde and 2% polyacrylamide hydrogel at 37°C for 4 h until transparent and ready for imaging.

[0085] Example 3

[0086] 1. Human skin samples were immersed in a mixture of 5% formaldehyde and 6% polyacrylamide hydrogel and fixed at room temperature for 3 days.

[0087] 2. The fixed samples were dehydrated stepwise in 20, 40, 60, 80, and 100% methanol / water solutions for 1 h.

[0088] 3. Wash twice with 100% methanol for 1 hour each time and cool the sample to 4°C;

[0089] 4. Immerse the sample in a methanol / dichloromethane solution with a volume ratio of 1:4 and place it on a decolorizing shaker at room temperature overnight.

[0090] 5. After washing with 100% methanol for 2 × 1 h, the samples were bleached with 4% H2O2 methanol at 4°C overnight.

[0091] 6. Rehydrate the sample in 80, 60, 40, and 20% methanol / water solutions for 1 h.

[0092] 7. Wash the samples quickly with PBS and then incubate them in 5% PBST for 2 × 1 h. After this step, the samples were processed for immunostaining.

[0093] 8. The samples were incubated in PBS, 0.2% Triton X-100, 10% DMSO, and 0.2 mol / L glycine at 37°C for 24 h.

[0094] 9. Then block in PBS, 0.2% Triton X-100, 10% DMSO, 20% goat serum, and 3% BSA at 37°C for 24 h.

[0095] 10. The samples were incubated in PBS, 0.2% Triton X-100, 10% DMSO, 20% goat serum, 3% BSA, and primary antibody solution at 37°C for 6 days.

[0096] 11. Wash the samples 5 times in PBS, 0.2% Triton X-100 until the next day.

[0097] 12. Then incubate at 37°C for 4 days in PBS, 0.2% Triton X-100, 10% DMSO, 20% goat serum, 3% BSA, and fluorescent secondary antibody solution.

[0098] 13. Finally, wash five times in PBS, 0.2% Triton X-100 until the next day.

[0099] 14. Finally, the samples were incubated in a mixture of 5% formaldehyde and 8% polyacrylamide hydrogel at 37°C for 4 h until transparent and ready for imaging.

[0100] Comparative Example 1

[0101] Human skin tissue (8.19 x 3.97 x 9.74 mm) was processed using the BBAB method.

[0102] 1. Fix the samples with 4% paraformaldehyde at 4°C for 1 day.

[0103] 2. Rinse 10 times with PBS and 0.3% Triton X-100, each wash for 30 minutes.

[0104] 3. Stain with primary antibody, secondary antibody and DAPI for 14 days.

[0105] 4. Rinse 10 times in PBS, 0.3% Triton X-100, each wash for 30 minutes.

[0106] 5. Dehydrate in 20, 40, 60, 80 and 100% methanol / water solutions in sequence.

[0107] 6. Use BABB reagent (benzyl benzoate / benzyl alcohol is 2:1) for transparent treatment for more than 7 days.

[0108] Comparative Example 2

[0109] 1. Fix the samples with 4% paraformaldehyde at 4°C for 1 day.

[0110] 2. Rinse 8 times with PBS, 8 minutes each time.

[0111] 3. The samples were transferred to CUBIC#1 solution for degreasing for 10 days. CUBIC#1 solution is urea (25%, w / v), N,N,N',N'-tetrakis(2-hydroxyethyl)ethylenediamine (25%, w / v), Triton X-100 (15%, v / v), and water (35%).

[0112] 4. Rinse 10 times with PBST solution (PBS, 0.1% Triton X-100), 30 minutes each time.

[0113] 5. Transfer the sample to CUBIC#2 solution for transparent treatment for more than 14 days. CUBIC#2 solution is urea (25%, w / v), sucrose (50%, w / v), triethanolamine (10%, w / v), and water (15%).

[0114] Comparative Example 3

[0115] 1. Human skin samples (6.26×6.9×8.28 mm) were immersed in a mixture of 4% formaldehyde and 0.6% polyacrylamide hydrogel and fixed at room temperature for 3 days.

[0116] The subsequent steps are consistent with those in Example 1.

[0117] Comparative Example 4

[0118] The concentration of the polyacrylamide hydrogel in step 1 is 8%; step 8 is omitted; and the other steps are consistent with those in Example 1.

[0119] Results Analysis

[0120] Figures 1 to 3The overall and local three-dimensional structures of the skin tissues of Examples 1 to 3 are clearly displayed. CD31 marks vascular endothelial cells to show the vascular network structure; PGP9.5 marks nerve fibers to show the neural network; DAPI marks the cell nucleus to show the cell position. The neural network and vascular network in each image present a complete three-dimensional structure without obvious fractures or deformations, indicating that the tissue maintains its natural structure and morphology during the transparent and staining process without shrinkage; the fluorescent labels of the nerve fibers and blood vessels in each image are clearly visible, indicating that the fluorescent signal is well preserved and the treatment method does not cause significant deformation or shrinkage of the tissue; the distribution of the nerve fibers and vascular networks in each image is uniform, showing the complex structure of each layer of the skin tissue, further proving the effectiveness of the treatment method in maintaining the tissue structure without causing local shrinkage or structural distortion. The fixation of tissue morphology enables deep imaging of tissue samples to be carried out effectively, while retaining key biomarkers and structural details, which is conducive to the reuse of the human skin tissue, such as embedding and slicing.

[0121] from Figure 4 It can be seen that the BABB method of Comparative Example 1 and the polyacrylamide hydrogel of Comparative Example 3 have a poor transparent effect on human skin tissue due to their low concentration, and the sample has severe shrinkage. Comparative Example 1 uses a mixed solvent of benzyl alcohol and phenyl benzoate to match the refractive index inside and outside the tissue, thereby reducing the scattering of light. However, the complex structure of human skin, especially the high fat and collagen content, may lead to insufficient refractive index matching, making the transparent effect unsatisfactory. Compared with other tissues, human skin has a more complex and dense structure. The multi-layer cells and rich extracellular matrix in the skin hinder the penetration and uniform distribution of BABB solvent, limiting its transparent ability. BABB solvent has a strong dehydration ability. In the transparent process, excessive dehydration causes the deformation of the tissue structure, affecting its biological integrity and functionality. The cross-linked network formed by the low concentration of polyacrylamide hydrogel in Comparative Example 3 is sparse and cannot provide sufficient mechanical support, resulting in significant shrinkage and deformation of the tissue structure during subsequent treatment (such as dehydration, degreasing and transparentization), affecting the morphology and structural integrity of the tissue.

[0122] according to Figure 5 It can be seen from AB that the transparent treatment of Comparative Example 2 makes the human skin tissue structure clearer, the color becomes lighter, and the transparency is improved. Figure 5 In C, the distribution of cell nuclei is relatively clear, indicating that the visualization effect of cell nuclei by the treatment of Comparative Example 2 is good. Figure 5The green signal shown in D is relatively fuzzy and unevenly distributed, indicating that under the treatment of Comparative Example 2, the antigenicity of PGP9.5 was damaged and failed to effectively mark nerve fibers. The urea used in Comparative Example 2 is a powerful protein denaturant that can destroy the three-dimensional structure of proteins. Although urea helps dehydrate and transparentize tissues, it also destroys the epitope of the antigen, making it impossible for the antibody to effectively recognize and bind to its target antigen. In addition, the CUBIC scheme of Comparative Example 2 includes long-term chemical treatment, and long-term exposure to chemical reagents will further affect the structure and antigenicity of the protein.

[0123] Figure 6 The three-dimensional neural imaging of human skin tissue in Comparative Example 4 is shown, and it can be seen that the distribution of cell nuclei is relatively clear. However, the dense network formed by the high concentration of polyacrylamide hydrogel will significantly reduce the infiltration of subsequent treatment reagents, making the degreasing process more difficult, reducing the efficiency of lipid removal, and affecting the final transparency effect. Omitting step 8 makes it more difficult for antibodies to penetrate into the deep layers of the tissue, resulting in uneven staining. It also weakens or makes the fluorescent signal of the deep structure of the skin tissue undetectable, making it impossible to successfully image the neural network or the details are not clear enough in the imaging. Therefore, step 8 is crucial to increase antibody permeability, reduce nonspecific binding, and improve staining effects.

[0124] Obviously, the above embodiments of the present invention are merely examples for clearly illustrating the present invention, and are not intended to limit the embodiments of the present invention. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the embodiments here. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the claims of the present invention.

Claims

1. A method for tissue clearing and three-dimensional staining, characterized in that: The following steps are involved: S1: Fix the tissue sample; S2: gradually dehydrate the tissue samples and then wash them; S3: pre-treating the tissue sample; S4: decolorizing the tissue sample; S5: gradually rehydrating the tissue sample; S6: hydrating the tissue sample; S7: tissue samples for tissue staining; S8: Incubate tissue samples until transparent and ready for imaging.

2. The tissue clearing and three-dimensional staining method according to claim 1, characterized in that: In S1, the tissue sample is immersed in formaldehyde and polyacrylamide hydrogel for fixation; the volume concentration of formaldehyde is 3-5%, and the volume concentration of polyacrylamide hydrogel is 1-6%.

3. The tissue clearing and three-dimensional staining method according to claim 1, characterized in that: In the step S8, the tissue sample is immersed in formaldehyde and polyacrylamide hydrogel for incubation; the volume concentration of the formaldehyde is 3-5%, and the volume concentration of the polyacrylamide hydrogel is 2-8%.

4. The tissue clearing and three-dimensional staining method according to claim 1, characterized in that: In S3, the tissue sample is immersed in methanol and dichloromethane for pretreatment; the volume ratio of methanol to dichloromethane is 1:2-4.

5. The tissue clearing and three-dimensional staining method according to claim 1, characterized in that: The S4 decolorizes the tissue sample in hydrogen peroxide and methanol; the volume concentration of hydrogen peroxide is 4-6%.

6. The tissue clearing and three-dimensional staining method according to claim 1, characterized in that: The S6 incubates and hydrates the tissue sample in Triton X-100, DMSO and glycine; the volume concentration of Triton X-100 is 0.2-5%, the volume concentration of DMSO is 10-20%, and the concentration of glycine is 0.2-0.4 mol / L.

7. The tissue clearing and three-dimensional staining method according to claim 1, characterized in that: The dehydration of S2 is carried out in methanol or ethanol with increasing concentration gradient, and the rehydration of S5 is carried out in methanol or ethanol with decreasing concentration gradient.

8. The tissue clearing and three-dimensional staining method according to claim 1, characterized in that: The S7 tissue sample is washed and incubated with PBST before being subjected to tissue immunostaining; the concentration of the PBST is 0.2-5%.

9. The tissue clearing and three-dimensional staining method according to any one of claims 1 to 6, characterized in that: Such tissues include skin, blood vessels, nerves, muscle, bone, brain, heart, liver, kidneys and lungs of humans and other animals.

10. An application of the tissue clearing and three-dimensional staining method according to claims 1 to 6, characterized in that: Applied in the field of human skin tissue repair and regeneration.

Citation Information

Cited By

  • Intrahepatic blood vessel three-dimensional imaging method based on non-diffracting Airy beam

    CN120052824A